<DOC>
	<DOCNO>NCT02302092</DOCNO>
	<brief_summary>The purpose study determine antibiotic Flomoxef performs well Cefepime treatment complicate urinary tract infection ( cUTIs ) Russian adult .</brief_summary>
	<brief_title>Efficacy Safety Flomoxef Versus Cefepime Treatment Participants With Urinary Tract Infections</brief_title>
	<detailed_description>The drug test study call Flomoxef . Flomoxef test people complicate urinary tract infection ( cUTI ) include kidney infection . This study compare Flomoxef Cefepime , another antibiotic . The study enroll approximately 80 participant . Participants randomly assign ( chance , like flip coin ) one two treatment group : - Flomoxef - intravenous infusion 2g twice daily ( every 12 hour ) ; - Cefepime - intravenous infusion 1g twice daily ( every 12 hour ) . This multi-center trial conduct ten site Russian Federation . The overall time participate study maximum 34 day . Participants make six visit clinic .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<mesh_term>Cefepime</mesh_term>
	<criteria>1 . Is man woman age 18 70 year , inclusive . 2 . Has pyuria ( white blood cell [ WBC ] count great 10/μL unspun urine great equal 10 per high power field spun urine ) . 3 . Has clinical sign and/or symptom complicate low urinary tract infection ( UTI ) and/or acute pyelonephritis include one following : fever ( i.e , axillary temperature great 37.7°C ) , chill , malaise , flank pain , back pain , and/or costovertebral angle pain tenderness and/or symptom dysuria ( dysuria , urinary urgency , urinary frequency , suprapubic discomfort , new urinary incontinence worsen preexist incontinence ) occur presence functional anatomical abnormality urinary tract presence catheterization . 4 . Has pretreatment baseline urine culture specimen obtain within 24 hour administration first dose study drug ( NOTE : Participants may enrol study start intravenous ( IV ) study drug therapy Investigator know result baseline urine culture ) . 5 . Requires IV antibacterial therapy treatment presume complicate UTI ( cUTI ) . 6 . In opinion investigator , capable understand comply protocol requirement . 7 . Signs date write , informed consent form require privacy authorization prior initiation study procedure , legally acceptable representative sign form . 8 . Meets protocolspecified criterion regard use contraception ; 9Is willing able comply study procedure . 1 . Has receive investigational compound within 30 day screen . 2 . Is immediate family member , study site employee , dependent relationship study site employee involve conduct study ( eg , spouse , parent , child , sibling ) may consent duress . 3 . Is female participant pregnant lactate intend become pregnant , , within one month participate study , intend donate ova time period . 4 . Is male participant intend donate sperm course study 12 week thereafter . 5 . Has participate another clinical study within past 30 day . 6 . Has history allergy intolerance betalactams ( penicillin , cephalosporin carbopenems ) . 7 . Has sign , symptom history condition , per protocol opinion investigator , might compromise : 1 ) safety wellbeing participant study staff , 2 ) safety wellbeing participant 's offspring ( pregnancy breastfeed ) , 3 ) analysis result . 8 . Has receive amount potentially therapeutic antibacterial therapy collection pretreatment baseline urine culture administration first dose study drug . 9 . Has receive dose potentially therapeutic antibacterial agent treatment current UTI within 48 hour provide pretreatment baseline urine culture specimen . 10 . Has current urinary catheter schedule remove EndofTherapy ( EOT ) visit ( intermittent straight catheterization IV study drug administration period acceptable ) . 11 . Has history trauma pelvis urinary tract within one year screen visit . 12 . Has contraindication medicine use study ( accord manufacturer 's instruction ) . 13 . Is consider unlikely survive fourweek study period rapidly progress disease immediately lifethreatening illness ( include acute hepatic failure , respiratory failure septic shock ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Drug Therapy</keyword>
</DOC>